47 OkadaR.MaedaK.NishiyamaT.AoyamaS.TozukaZ.HiratsukaA.et al (2011)
When researchers gave semaglutide to pregnant rats at human clinical doses, they observed: Increased fetal death Structural abnormalities including abnormal heart blood vessels Changes in skeletal structures Early pregnancy losses in rabbits and cynomolgus monkeys at human-equivalent exposure levels That said, context matters
What do GLP-1 medications do
Guitera P, Moloney FJ, Menzies SW, Stretch JR, Quinn MJ, Hong A, Fogarty G, Scolyer RA
These are much less common now we have developed much more robust glove making systems
Activating glucagon receptors in cardiac tissue raises heart rate